109 related articles for article (PubMed ID: 9688294)
1. Risk of relapse and clinico-pathological features in 103 patients with diffuse large-cell lymphoma in complete response after first-line treatment.
Sanz L; López-Guillermo A; Martínez C; Bosch F; Esteve J; Cobo F; Montoto S; Perales M; Bladé J; Cervantes F; Nomdedeu B; Campo E; Montserrat E
Eur J Haematol; 1998 Jul; 61(1):59-64. PubMed ID: 9688294
[TBL] [Abstract][Full Text] [Related]
2. Late relapse in patients with diffuse large-cell lymphoma treated with MACOP-B.
Lee AY; Connors JM; Klimo P; O'Reilly SE; Gascoyne RD
J Clin Oncol; 1997 May; 15(5):1745-53. PubMed ID: 9164181
[TBL] [Abstract][Full Text] [Related]
3. Prognostic features and outcome in patients with diffuse large B-cell lymphoma who do not achieve a complete response to first-line regimens.
Villela L; López-Guillermo A; Montoto S; Rives S; Bosch F; Perales M; Ferrer A; Esteve J; Colomo L; Campo E; Montserrat E
Cancer; 2001 Apr; 91(8):1557-62. PubMed ID: 11301405
[TBL] [Abstract][Full Text] [Related]
4. Late relapse in patients with diffuse large B-cell lymphoma.
Vose JM; Weisenburger DD; Loberiza FR; Arevalo A; Bast M; Armitage J; Bierman PJ; Bociek RG; Armitage JO
Br J Haematol; 2010 Nov; 151(4):354-8. PubMed ID: 20880118
[TBL] [Abstract][Full Text] [Related]
5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
6. [Clinical pathologic characteristics and treatment outcomes of 19 relapsed pediatric B-cell lymphoma].
Huang S; Jin L; Yang J; Duan YL; Zhang M; Zhou CJ; Ma XL; Zhang YH
Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):748-753. PubMed ID: 29050112
[No Abstract] [Full Text] [Related]
7. Waldeyer's ring lymphomas: a clinical study from the Comprehensive Cancer Center West population based NHL registry.
Krol AD; Le Cessie S; Snijder S; Kluin-Nelemans JC; Kluin PM; Noorduk EM
Leuk Lymphoma; 2001; 42(5):1005-13. PubMed ID: 11697617
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma.
Aksentijevich I; Jones RJ; Ambinder RF; Garrett-Mayer E; Flinn IW
Biol Blood Marrow Transplant; 2006 Sep; 12(9):965-72. PubMed ID: 16920563
[TBL] [Abstract][Full Text] [Related]
9. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
[TBL] [Abstract][Full Text] [Related]
10. Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas.
Guglielmi C; Martelli M; Federico M; Zinzani PL; Vitolo U; Bellesi G; Santini G; Tarella C; Zallio F; Pregno P; Di Renzo N; Resegotti L;
Haematologica; 2001 Sep; 86(9):941-50. PubMed ID: 11532622
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Risk of Relapse for Patients with Stage I-II Diffuse Large B-cell Lymphoma Treated in First Line with Immunochemotherapy.
Mercadal S; Climent F; Domingo-Doménech E; Oliveira A; Romagosa V; de Sevilla AF; González-Barca E
Clin Med Insights Blood Disord; 2013; 6():23-7. PubMed ID: 25512717
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of diffuse large B-cell lymphoma patients relapsing after autologous stem cell transplantation: an analysis of patients included in the CORAL study.
Van Den Neste E; Schmitz N; Mounier N; Gill D; Linch D; Trneny M; Bouadballah R; Radford J; Bargetzi M; Ribrag V; Dührsen U; Ma D; Briere J; Thieblemont C; Bachy E; Moskowitz CH; Glass B; Gisselbrecht C
Bone Marrow Transplant; 2017 Feb; 52(2):216-221. PubMed ID: 27643872
[TBL] [Abstract][Full Text] [Related]
13. Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse.
Robertson LE; Redman JR; Butler JJ; Osborne BM; Velasquez WS; McLaughlin P; Swan F; Rodriguez MA; Hagemeister FB; Fuller LM
J Clin Oncol; 1991 Feb; 9(2):236-42. PubMed ID: 1988571
[TBL] [Abstract][Full Text] [Related]
14. Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma.
Cabanillas F; Velasquez WS; Hagemeister FB; McLaughlin P; Redman JR
Blood; 1992 Feb; 79(4):1024-8. PubMed ID: 1737086
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes associated with very late relapses in diffuse large cell lymphoma.
Ko AH; Yuen AR
Leuk Lymphoma; 2002 Sep; 43(9):1789-93. PubMed ID: 12685833
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
17. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
[TBL] [Abstract][Full Text] [Related]
18. Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation.
Fuller LM; Krasin MJ; Velasquez WS; Allen PK; McLaughlin P; Rodriguez MA; Hagemeister FB; Swan F; Cabanillas F; Palmer JL
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):3-11. PubMed ID: 7527799
[TBL] [Abstract][Full Text] [Related]
19. Role of hematopoietic stem cell transplantation for advanced-stage diffuse large cell B-cell lymphoma-B.
Nademanee A; Forman SJ
Semin Hematol; 2006 Oct; 43(4):240-50. PubMed ID: 17027658
[TBL] [Abstract][Full Text] [Related]
20. MACOP-B treatment in diffuse large-cell lymphoma: identification of prognostic groups in an Italian multicenter study.
Vitolo U; Bertini M; Brusamolino E; Cavallero GB; Comotti B; Gallo E; Ghio R; Levis A; Luxi G; Meneghini V
J Clin Oncol; 1992 Feb; 10(2):219-27. PubMed ID: 1370690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
